Cogent Biosciences
COGT
#2690
Rank
HK$48.13 B
Marketcap
HK$313.54
Share price
3.95%
Change (1 day)
316.78%
Change (1 year)

Revenue for Cogent Biosciences (COGT)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Cogent Biosciences from 2017 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A
2023 N/A
2022 N/A
2021 N/A-100%
2020 HK$61.01 M-65.18%
2019 HK$0.17 B129.87%
2018 HK$76.22 M16.7%
2017 HK$65.31 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Onconova Therapeutics
ONTX
HK$1.75 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
HK$4.99 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA